NasdaqGS - Delayed Quote
USD
Apnimed, Inc. (APMD)
15.10
+0.94
(+6.64%)
At close: November 6 at 4:00:01 PM EST
15.10
-0.01
(-0.10%)
After hours: November 6 at 4:01:21 PM EST
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Kevin Robert Lind
|
CEO & Director | -- | -- | 1976 |
|
Dr. Lawrence G. Miller M.D., M.P.H.
|
Founder & Vice Chair of the Board | 805.85k | -- | 1954 |
|
Mr. Dennis Patrick Molnar M.B.A.
|
President & COO | 645.8k | -- | 1969 |
|
Dr. Luigi Taranto Montemurro M.D.
|
Co-Founder & Chief Scientific Officer | -- | -- | 1979 |
|
Mr. Michael B. Kelly
|
Chief Financial Officer | -- | -- | 1975 |
|
Ms. Leila Sylvain
|
Senior Manager of Administration | -- | -- | -- |
|
Mr. Steven W. Spector J.D.
|
Chief Legal Officer & Head of Corporate Affairs | -- | -- | 1965 |
|
Ms. Jennifer Patterson
|
Senior Vice President of Human Resources | -- | -- | -- |
|
Dr. John W. Cronin M.D.
|
Chief Medical Officer | -- | -- | 1968 |
|
Dr. Sean M. Johnston M.B.A., Ph.D.
|
Consulting Head of CMC | -- | -- | 1958 |
Apnimed, Inc.
39 John F. Kennedy Street
4th Floor
Cambridge, MA 02138
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 81
Description
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Corporate Governance
Apnimed, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 11, 2026 at 9:00 PM UTC
Apnimed, Inc. Earnings Date
